Dr Katie Ewer | PI, Senior Immunologist-Malaria and Ebola Vaccine Trials
University of Oxford

Dr Katie Ewer, PI, Senior Immunologist-Malaria and Ebola Vaccine Trials, University of Oxford

As the senior immunologist for the Ebola and pre-erythrocytic malaria vaccine trials, Katie oversees the immunology on Phase I and II trials of vectored vaccines, both in the UK and in field trials in Africa. She uses the chimpanzee adenovirus, ChAd63, as a priming vector and modified vaccinia virus (MVA) as a boosting vaccination and these viruses encode proteins from the organism that can elicit protective immune responses in our vaccinated volunteers. Her work contributes to the vaccine development process to improve the immunogenicity of our viral vectors for future trials and hopefully increase vaccine efficacy.


Day Three 12th October, Human @ 10:10

Viral vectors as vaccine platforms: From immunogenicity to impact

back to speakers